167 related articles for article (PubMed ID: 23409864)
1. Compound and compositions as TGR5 agonists: WO2012082947.
Raval S
Expert Opin Ther Pat; 2013 Apr; 23(4):531-6. PubMed ID: 23409864
[TBL] [Abstract][Full Text] [Related]
2. Patented TGR5 modulators: a review (2006 - present).
Gioiello A; Rosatelli E; Nuti R; Macchiarulo A; Pellicciari R
Expert Opin Ther Pat; 2012 Dec; 22(12):1399-414. PubMed ID: 23039746
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of anti-diabetic effect and gall bladder function with 2-thio-5-thiomethyl substituted imidazoles as TGR5 receptor agonists.
Zhang X; Sui Z; Kauffman J; Hou C; Chen C; Du F; Kirchner T; Liang Y; Johnson D; Murray WV; Demarest K
Bioorg Med Chem Lett; 2017 Apr; 27(8):1760-1764. PubMed ID: 28285911
[TBL] [Abstract][Full Text] [Related]
4. Acyl hydroxypyrazoles as novel agonists for high-affinity nicotinic acid receptor GPR109A: WO2008051403.
Shen HC
Expert Opin Ther Pat; 2009 Aug; 19(8):1149-55. PubMed ID: 19566484
[TBL] [Abstract][Full Text] [Related]
5. Discovery of 5-phenoxy-1,3-dimethyl-1H-pyrazole-4-carboxamides as potent agonists of TGR5 via sequential combinatorial libraries.
Londregan AT; Piotrowski DW; Futatsugi K; Warmus JS; Boehm M; Carpino PA; Chin JE; Janssen AM; Roush NS; Buxton J; Hinchey T
Bioorg Med Chem Lett; 2013 Mar; 23(5):1407-11. PubMed ID: 23337601
[TBL] [Abstract][Full Text] [Related]
6. Discovery of structurally novel, potent and orally efficacious GPR119 agonists.
Alper P; Azimioara M; Cow C; Mutnick D; Nikulin V; Michellys PY; Wang Z; Reding E; Paliotti M; Li J; Bao D; Zoll J; Kim Y; Zimmerman M; Groessel T; Tuntland T; Joseph SB; McNamara P; Seidel HM; Epple R
Bioorg Med Chem Lett; 2014 May; 24(10):2383-7. PubMed ID: 24751443
[TBL] [Abstract][Full Text] [Related]
7. Novel potent and selective bile acid derivatives as TGR5 agonists: biological screening, structure-activity relationships, and molecular modeling studies.
Sato H; Macchiarulo A; Thomas C; Gioiello A; Une M; Hofmann AF; Saladin R; Schoonjans K; Pellicciari R; Auwerx J
J Med Chem; 2008 Mar; 51(6):1831-41. PubMed ID: 18307294
[TBL] [Abstract][Full Text] [Related]
8. Treatment and prevention of various therapeutic conditions using OX receptor antagonistic activity (WO2012081692).
Christopher JA; Congreve MS
Expert Opin Ther Pat; 2013 Feb; 23(2):273-7. PubMed ID: 23282091
[TBL] [Abstract][Full Text] [Related]
9. Fluorinated pyrazole acids are agonists of the high affinity niacin receptor GPR109a.
Skinner PJ; Cherrier MC; Webb PJ; Shin YJ; Gharbaoui T; Lindstrom A; Hong V; Tamura SY; Dang HT; Pride CC; Chen R; Richman JG; Connolly DT; Semple G
Bioorg Med Chem Lett; 2007 Oct; 17(20):5620-3. PubMed ID: 17804224
[TBL] [Abstract][Full Text] [Related]
10. Pharmacophore modeling, comprehensive 3D-QSAR, and binding mode analysis of TGR5 agonists.
Sindhu T; Srinivasan P
J Recept Signal Transduct Res; 2017 Apr; 37(2):109-123. PubMed ID: 27267434
[TBL] [Abstract][Full Text] [Related]
11. Molecular field analysis and 3D-quantitative structure-activity relationship study (MFA 3D-QSAR) unveil novel features of bile acid recognition at TGR5.
Macchiarulo A; Gioiello A; Thomas C; Massarotti A; Nuti R; Rosatelli E; Sabbatini P; Schoonjans K; Auwerx J; Pellicciari R
J Chem Inf Model; 2008 Sep; 48(9):1792-801. PubMed ID: 18698841
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and structure-activity relationships of 3,4,5-trisubstituted 4,5-dihydro-1,2,4-oxadiazoles as TGR5 agonists.
Zhu J; Ye Y; Ning M; Mándi A; Feng Y; Zou Q; Kurtán T; Leng Y; Shen J
ChemMedChem; 2013 Jul; 8(7):1210-23. PubMed ID: 23757200
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of novel TGR5 agonist in combination with Sitagliptin for possible treatment of type 2 diabetes.
Agarwal S; Sasane S; Kumar J; Deshmukh P; Bhayani H; Giri P; Giri S; Soman S; Kulkarni N; Jain M
Bioorg Med Chem Lett; 2018 Jun; 28(10):1849-1852. PubMed ID: 29655980
[TBL] [Abstract][Full Text] [Related]
14. GPR119 agonists for the treatment of type 2 diabetes.
Jones RM; Leonard JN; Buzard DJ; Lehmann J
Expert Opin Ther Pat; 2009 Oct; 19(10):1339-59. PubMed ID: 19780700
[TBL] [Abstract][Full Text] [Related]
15. Discovery and optimization of a novel series of GPR142 agonists for the treatment of type 2 diabetes mellitus.
Lizarzaburu M; Turcotte S; Du X; Duquette J; Fu A; Houze J; Li L; Liu J; Murakoshi M; Oda K; Okuyama R; Nara F; Reagan J; Yu M; Medina JC
Bioorg Med Chem Lett; 2012 Sep; 22(18):5942-7. PubMed ID: 22884988
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and antidiabetic activity of 4-phenoxynicotinamide and 4-phenoxypyrimidine-5-carboxamide derivatives as potent and orally efficacious TGR5 agonists.
Duan H; Ning M; Chen X; Zou Q; Zhang L; Feng Y; Zhang L; Leng Y; Shen J
J Med Chem; 2012 Dec; 55(23):10475-89. PubMed ID: 23148522
[TBL] [Abstract][Full Text] [Related]
17. TGR5 agonists for diabetes treatment: a patent review and clinical advancements (2012-present).
Bhimanwar RS; Mittal A
Expert Opin Ther Pat; 2022 Feb; 32(2):191-209. PubMed ID: 34652989
[TBL] [Abstract][Full Text] [Related]
18. Discovery of 6alpha-ethyl-23(S)-methylcholic acid (S-EMCA, INT-777) as a potent and selective agonist for the TGR5 receptor, a novel target for diabesity.
Pellicciari R; Gioiello A; Macchiarulo A; Thomas C; Rosatelli E; Natalini B; Sardella R; Pruzanski M; Roda A; Pastorini E; Schoonjans K; Auwerx J
J Med Chem; 2009 Dec; 52(24):7958-61. PubMed ID: 20014870
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and SAR of 2-aryl-3-aminomethylquinolines as agonists of the bile acid receptor TGR5.
Herbert MR; Siegel DL; Staszewski L; Cayanan C; Banerjee U; Dhamija S; Anderson J; Fan A; Wang L; Rix P; Shiau AK; Rao TS; Noble SA; Heyman RA; Bischoff E; Guha M; Kabakibi A; Pinkerton AB
Bioorg Med Chem Lett; 2010 Oct; 20(19):5718-21. PubMed ID: 20801037
[TBL] [Abstract][Full Text] [Related]
20. 2-Phenoxy-nicotinamides are potent agonists at the bile acid receptor GPBAR1 (TGR5).
Martin RE; Bissantz C; Gavelle O; Kuratli C; Dehmlow H; Richter HG; Obst Sander U; Erickson SD; Kim K; Pietranico-Cole SL; Alvarez-Sánchez R; Ullmer C
ChemMedChem; 2013 Apr; 8(4):569-76. PubMed ID: 23225346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
